JP2022525416A5 - - Google Patents
Info
- Publication number
- JP2022525416A5 JP2022525416A5 JP2021555813A JP2021555813A JP2022525416A5 JP 2022525416 A5 JP2022525416 A5 JP 2022525416A5 JP 2021555813 A JP2021555813 A JP 2021555813A JP 2021555813 A JP2021555813 A JP 2021555813A JP 2022525416 A5 JP2022525416 A5 JP 2022525416A5
- Authority
- JP
- Japan
- Prior art keywords
- day
- peptide
- mimicking
- administered
- days
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962819195P | 2019-03-15 | 2019-03-15 | |
| US62/819,195 | 2019-03-15 | ||
| US201962926018P | 2019-10-25 | 2019-10-25 | |
| US62/926,018 | 2019-10-25 | ||
| PCT/US2020/022682 WO2020190742A1 (en) | 2019-03-15 | 2020-03-13 | Peptidomimetic macrocycles and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022525416A JP2022525416A (ja) | 2022-05-13 |
| JP2022525416A5 true JP2022525416A5 (enExample) | 2023-03-20 |
Family
ID=72424829
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021555813A Pending JP2022525416A (ja) | 2019-03-15 | 2020-03-13 | ペプチド模倣大環状分子およびその使用 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20200289609A1 (enExample) |
| EP (1) | EP3938051A4 (enExample) |
| JP (1) | JP2022525416A (enExample) |
| CN (1) | CN114173878A (enExample) |
| AU (1) | AU2020241429A1 (enExample) |
| CA (1) | CA3132993A1 (enExample) |
| WO (1) | WO2020190742A1 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113880766B (zh) * | 2020-07-04 | 2023-10-31 | 成都先导药物开发股份有限公司 | 一种免疫调节剂 |
| WO2023096947A1 (en) * | 2021-11-29 | 2023-06-01 | Merck Sharp & Dohme Llc | C-terminal extended p53 activator crosslinked peptidomimetic macrocycles against mdm2/mdmx |
| JP2024546110A (ja) * | 2021-12-10 | 2024-12-17 | メルク・シャープ・アンド・ドーム・エルエルシー | Ｐ５３ペプチド模倣大環状分子 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104474529A (zh) * | 2008-02-08 | 2015-04-01 | 爱勒让治疗公司 | 治疗性的拟肽大环化合物 |
| KR102104762B1 (ko) * | 2010-08-13 | 2020-04-24 | 에일러론 테라퓨틱스 인코포레이티드 | 펩티도미메틱 거대고리 |
| RU2642299C2 (ru) * | 2012-02-15 | 2018-01-24 | Эйлерон Терапьютикс, Инк. | P53 пептидомиметические макроциклы |
| CN107106642B (zh) * | 2014-09-24 | 2021-02-26 | 艾瑞朗医疗公司 | 拟肽大环化合物及其制剂 |
| JP2018516844A (ja) * | 2015-03-20 | 2018-06-28 | エルロン・セラピューティクス・インコーポレイテッドＡｉｌｅｒｏｎ Ｔｈｅｒａｐｅｕｔｉｃｓ，Ｉｎｃ． | ペプチド模倣大環状分子およびその使用 |
| CA2996685A1 (en) * | 2015-09-03 | 2017-03-09 | Aileron Therapeutics, Inc. | Peptidomimetic macrocycles and uses thereof |
| WO2017205786A1 (en) * | 2016-05-27 | 2017-11-30 | Aileron Therapeutics, Inc. | Cell permeable peptidomimetic macrocycles |
| CN110891588A (zh) * | 2017-05-11 | 2020-03-17 | 艾瑞朗医疗公司 | 拟肽大环化合物及其用途 |
| WO2020023502A1 (en) * | 2018-07-23 | 2020-01-30 | Aileron Therapeutics, Inc. | Peptidomimetic macrocycles and uses thereof |
-
2020
- 2020-03-13 EP EP20773620.8A patent/EP3938051A4/en not_active Withdrawn
- 2020-03-13 US US16/818,284 patent/US20200289609A1/en not_active Abandoned
- 2020-03-13 AU AU2020241429A patent/AU2020241429A1/en not_active Abandoned
- 2020-03-13 CN CN202080036270.1A patent/CN114173878A/zh active Pending
- 2020-03-13 WO PCT/US2020/022682 patent/WO2020190742A1/en not_active Ceased
- 2020-03-13 JP JP2021555813A patent/JP2022525416A/ja active Pending
- 2020-03-13 CA CA3132993A patent/CA3132993A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20200369728A1 (en) | Peptidomimetic macrocycles and uses thereof | |
| EP2091965B9 (en) | Peptide vaccines for cancers expressing mphosph1 or depdc1 polypeptides | |
| RU2571551C1 (ru) | Специфическая сочетанная терапия злокачественных опухолей цитостатиком и его модификатором | |
| JP2012510430A5 (enExample) | ||
| ES2354359T3 (es) | Ácidos nucleicos útiles para desencadenar la mortalidad de células tumorales. | |
| JP2013500253A (ja) | ７−エチル−１０−ヒドロキシカンプトテシンのマルチアーム型ポリマー性複合体と組み合わせたｈｅｒ２受容体拮抗薬を用いるｈｅｒ２陽性がんの治療方法 | |
| US11091522B2 (en) | Peptidomimetic macrocycles and uses thereof | |
| JP2015508777A5 (enExample) | ||
| JP2012515172A5 (enExample) | ||
| JP2010518006A5 (enExample) | ||
| ES2639577T3 (es) | Vacuna para la prevención de la recurrencia del cáncer de mama | |
| JP2017533889A5 (enExample) | ||
| ES2988496T3 (es) | Compuestos y métodos para tratar el cáncer | |
| US8685928B2 (en) | Antagonists of MUC1 | |
| MX2010013680A (es) | Peptidos del epitope iqgap3 y vacunas que los contienen. | |
| CN102333520B (zh) | 癌症的预防或治疗剂 | |
| US20180371021A1 (en) | Peptidomimetic macrocycles and uses thereof | |
| JP2024516613A5 (enExample) | ||
| Chatzistamou et al. | Inhibition of growth of OV-1063 human epithelial ovarian cancers and c-jun and c-fos oncogene expression by bombesin antagonists | |
| JPWO2020071551A5 (enExample) | ||
| CA2432971A1 (en) | Polypeptides | |
| JP2022525416A (ja) | ペプチド模倣大環状分子およびその使用 | |
| Löhr et al. | Novel treatments and therapies in development for pancreatic cancer | |
| EP4378473A1 (en) | Her2 vaccine composition | |
| JP2002265495A (ja) | 塩基性を有した新規なデンドリマーまたはその薬学的に許容される塩、並びに血管新生阻害剤 |